Details for Patent: 7,777,050
✉ Email this page to a colleague
Which drugs does patent 7,777,050 protect, and when does it expire?
Patent 7,777,050 protects MEKTOVI and is included in one NDA.
This patent has one hundred and twenty-three patent family members in thirty-four countries.
Summary for Patent: 7,777,050
| Title: | N3 alkylated benzimidazole derivatives as MEK inhibitors |
| Abstract: | Disclosed are compounds of the Formula I ##STR00001## and pharmaceutically acceptable salts and prodrugs thereof, wherein W, R.sup.1, R.sup.2, R.sup.7, R.sup.8, R.sup.9 and R.sup.10 are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed is a method of using such compounds in the treatment of hyperproliferative diseases in mammals, and pharmaceutical compositions containing such compounds. |
| Inventor(s): | Wallace; Eli M. (Lyons, CO), Lyssikatos; Joseph P. (Superior, CO), Marlow; Allison L. (Boulder, CO), Hurley; T. Brian (Boulder, CO) |
| Assignee: | Array BioPharma Inc. (Boulder, CO) |
| Application Number: | 12/050,827 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
More… ↓ |
Drugs Protected by US Patent 7,777,050
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Array Biopharma Inc | MEKTOVI | binimetinib | TABLET;ORAL | 210498-001 | Jun 27, 2018 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,777,050
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1482932 | ⤷ Subscribe | PA2019007 | Lithuania | ⤷ Subscribe |
| European Patent Office | 1482932 | ⤷ Subscribe | LUC00100 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 1482932 | ⤷ Subscribe | 300974 | Netherlands | ⤷ Subscribe |
| European Patent Office | 1482932 | ⤷ Subscribe | 2019C/510 | Belgium | ⤷ Subscribe |
| European Patent Office | 1482932 | ⤷ Subscribe | CA 2019 00011 | Denmark | ⤷ Subscribe |
| European Patent Office | 1482932 | ⤷ Subscribe | C20190010 00281 | Estonia | ⤷ Subscribe |
| European Patent Office | 1482932 | ⤷ Subscribe | 14/2019 | Austria | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
